Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)

NCT04089267 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
288
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shenyang Sunshine Pharmaceutical Co., LTD.